THERAVANCE BIOPHARMA INC

CUSIP: 88339KAA0 Class: NOTE

Rock Springs Capital Management LP's Holding History (CIK: 0001595725)

Note: Option positions (PUT/CALL) are excluded.

Q2 2022
Shares 1,500,000 Value ($000) $1,381 Avg Close Range
Q1 2022
Shares 1,500,000 Value ($000) $1,420 Avg Close Range
Q4 2021
Shares 1,500,000 Value ($000) $1,456 Avg Close Range
Q3 2021
Shares 1,500,000 Value ($000) $1,391 Avg Close Range
Q2 2021
Shares 1,500,000 Value ($000) $1,429 Avg Close Range
Q1 2021
Shares 1,500,000 Value ($000) $1,526 Avg Close Range
Q4 2020
Shares 1,500,000 Value ($000) $1,420 Avg Close Range
Q3 2020
Shares 1,500,000 Value ($000) $1,320 Avg Close Range
Q2 2020
Shares 1,500,000 Value ($000) $1,460 Avg Close Range
Q1 2020
Shares 1,500,000 Value ($000) $1,448 Avg Close Range
Q4 2019
Shares 1,500,000 Value ($000) $1,557 Avg Close Range
Q3 2019
Shares 1,500,000 Value ($000) $1,376 Avg Close Range
Q2 2019
Shares 1,500,000 Value ($000) $1,290 Avg Close Range
Q1 2019
Shares 1,500,000 Value ($000) $1,457 Avg Close Range
Q4 2018
Shares 1,500,000 Value ($000) $1,547 Avg Close Range
Q3 2018
Shares 1,500,000 Value ($000) $1,770 Avg Close Range
Q2 2018
Shares 1,500,000 Value ($000) $1,491 Avg Close Range
Q1 2018
Shares 1,500,000 Value ($000) $1,515 Avg Close Range
Q4 2017
Shares 1,500,000 Value ($000) $1,645 Avg Close Range
Q3 2017
Shares 1,500,000 Value ($000) $1,844 Avg Close Range
Q2 2017
Shares 1,500,000 Value ($000) $2,032 Avg Close Range
Q1 2017
Shares 1,500,000 Value ($000) $1,899 Avg Close Range
Q4 2016
Shares 1,500,000 Value ($000) $1,713 Avg Close Range